Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-25-035821·COLUMN GROUP III, LP
Schedule 13D ownership disclosure
Tenaya Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 87990A106
Event date: 2025-03-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- The Column Group III, LPReported CIK 0001668159
Shares: 4,414,720 · Class: 2.9%
- The Column Group III-A, LPReported CIK 0001668085
Shares: 4,985,570 · Class: 3.2%
- The Column Group III GP, LPReported CIK 0001790965
Shares: 9,400,290 · Class: 6.1%
- The Column Group Opportunity III, LPReported CIK 0001931825
Shares: 49,313,559 · Class: 32.0%
- The Column Group Opportunity III GP, LPReported CIK 0001932874
Shares: 49,313,559 · Class: 32.0%
- TCG Opportunity III GP, LLCReported CIK 0001932445
Shares: 49,313,559 · Class: 32.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-035821
- Form type
- SCHEDULE 13D/A
- Filer
- COLUMN GROUP III, LP
- CIK
- CIK 1668159
- Filed
- Mar 07, 2025
- Reporting period
- Mar 05, 2025
- Description
- Schedule 13D beneficial ownership